Biosimilars There is a market potential for biosimilars by 2019 when 50% of the biologics market is forecast to belong to off-patent drugs as there is tremendous interest by big pharma and generics companies in biosimilars industry, according to the new Global & USA Biosimilar Market Analysis to 2021 research report, available from ReportsnReports.com. 14 August 2015